Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Beta for Post-Kidney Transplant Anaemia
2006-003502-26Phase 4Completed
- Sponsor
- Barts Health NHS Trust
- Start
- Oct 2006
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of epoetin beta in anaemia (2 arms), sponsored by Barts Health NHS Trust. Primary endpoints: Change in estimated glomerular filtration rate, Rate of decline of renal function and 2 more. Started Oct 2006; status: completed.
02
Drugs
epoetin beta
03
Conditions
anaemia
Beyond the preview
Go deeper on 2006-003502-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003502-26.